Molecular alterations with hyperprogression in lung cancer patients treated with immune checkpoint inhibitors in a large health system

Authors

Eyob Tadesse, Advocate Aurora HealthFollow
Kayla Heslin, Advocate Aurora HealthFollow
Mohamed Hendawi, Advocate Aurora HealthFollow
Jonathan Hirsch
Christopher Idyro
Michael A. Thompson, Advocate Aurora HealthFollow

Recommended Citation

Tadesse E, Heslin K, Hendawi M, et al. Molecular alterations with hyperprogression in lung cancer patients treated with immune checkpoint inhibitors in a large health system. Journal of Clinical Oncology. 2020; 38(15S):e15082.

Affiliations

Aurora Cancer Care, Aurora Research Institute

Document Type

Abstract